MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
|
Back to Search Results |
|
Model Number 8637-40 |
Device Problems
Difficult to Interrogate (1331); Migration or Expulsion of Device (1395); Material Integrity Problem (2978)
|
Patient Problems
Insufficient Information (4580); No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 01/30/2024 |
Event Type
Injury
|
Manufacturer Narrative
|
Continuation of d10: product id: 8780, serial# (b)(6), implanted: (b)(6) 2017, explanted: (b)(6) 2024, product type catheter.Section d information references the main component of the system.Other relevant device(s) are: product id: 8780, serial/lot #: (b)(6), ubd: 02-dec-2018, udi#: (b)(4).Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a consumer and health care provider (hcp) via a manufacturer representative (rep) regarding a patient receiving intrathecal baclofen 2000 mcg/ml at 220 mcg/day via an implantable pump for unknown indications for use.It was reported that the patient said she bent over and felt a ¿pop¿ a few weeks ago and kept feeling the pump flip.The patient visited her physiatrist last week and they did a dose reduction and he had a very difficult time connecting to her pump.The dose reduction was to 220 mcg and it was unknown what the dose was prior to reduction.It was further reported that upon exposure of pump, the pump was flipped and the catheter was twisted multiple times and the catheter was broken.The catheter that was broken off and connected to pump was measured by the surgeon to be approximately 70 cm.An anterior-posterior (ap) x-ray was performed and catheter tip was found at approximately t9.The surgeon declined lateral.The patient was positioned supine and the surgeon stated that the risk of infection was too high to change to prone or lateral.The surgeon stated the plan was to bring the patient back in for a prone procedure to remove the remaining approximately 20 cm of catheter, once the pocket incision began to heal.If at that time, the patient and the patient's physiatrist felt it was best to move forward with another implant they would do so.Actions/interventions taken to resolve the issue included a dose reduction and planned surgery.The issue was not resolved at the time of the event and the patient's status was "alive-no injury".The patient's weight and medical history was asked but was unknown.
|
|
Manufacturer Narrative
|
H6 correction: fdm code b20 does not apply and was corrected to b18.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received from a healthcare provider (hcp) via a company representative (rep) stated that the hcp performed a revision in a hospital.No further information.
|
|
Search Alerts/Recalls
|
|
|